Search

Your search keyword '"Xue‐sheng Li"' showing total 9 results
Start Over Author "Xue‐sheng Li" Publisher american association for cancer research (aacr)
9 results on '"Xue‐sheng Li"'

1. Supplementary Table S1 from Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies

Author

Zhai, Yifan, primary, Tang, Qiuqiong, primary, Fang, Douglas D., primary, Deng, Jing, primary, Zhang, Kaixiang, primary, Wang, Qixin, primary, Yin, Yan, primary, Fu, Chengcheng, primary, Xue, Sheng-Li, primary, Li, Na, primary, Zhou, Feng, primary, and Yang, Dajun, primary

Published
2023
Full Text
View/download PDF

2. Supplementary Figures S1-S5 from Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies

Author

Zhai, Yifan, primary, Tang, Qiuqiong, primary, Fang, Douglas D., primary, Deng, Jing, primary, Zhang, Kaixiang, primary, Wang, Qixin, primary, Yin, Yan, primary, Fu, Chengcheng, primary, Xue, Sheng-Li, primary, Li, Na, primary, Zhou, Feng, primary, and Yang, Dajun, primary

Published
2023
Full Text
View/download PDF

3. Supplementary Table S1 from Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies

Author

Zhai, Yifan, primary, Tang, Qiuqiong, primary, Fang, Douglas D., primary, Deng, Jing, primary, Zhang, Kaixiang, primary, Wang, Qixin, primary, Yin, Yan, primary, Fu, Chengcheng, primary, Xue, Sheng-Li, primary, Li, Na, primary, Zhou, Feng, primary, and Yang, Dajun, primary

Published
2023
Full Text
View/download PDF

4. Supplementary Appendix 1 from Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies

Author

Zhai, Yifan, primary, Tang, Qiuqiong, primary, Fang, Douglas D., primary, Deng, Jing, primary, Zhang, Kaixiang, primary, Wang, Qixin, primary, Yin, Yan, primary, Fu, Chengcheng, primary, Xue, Sheng-Li, primary, Li, Na, primary, Zhou, Feng, primary, and Yang, Dajun, primary

Published
2023
Full Text
View/download PDF

5. Supplementary Appendix 1 from Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies

Author

Zhai, Yifan, primary, Tang, Qiuqiong, primary, Fang, Douglas D., primary, Deng, Jing, primary, Zhang, Kaixiang, primary, Wang, Qixin, primary, Yin, Yan, primary, Fu, Chengcheng, primary, Xue, Sheng-Li, primary, Li, Na, primary, Zhou, Feng, primary, and Yang, Dajun, primary

Published
2023
Full Text
View/download PDF

6. Supplementary Figures S1-S5 from Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies

Author

Zhai, Yifan, primary, Tang, Qiuqiong, primary, Fang, Douglas D., primary, Deng, Jing, primary, Zhang, Kaixiang, primary, Wang, Qixin, primary, Yin, Yan, primary, Fu, Chengcheng, primary, Xue, Sheng-Li, primary, Li, Na, primary, Zhou, Feng, primary, and Yang, Dajun, primary

Published
2023
Full Text
View/download PDF

9. Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies

Author

Zhai, Yifan, primary, Tang, Qiuqiong, additional, Fang, Douglas D., additional, Deng, Jing, additional, Zhang, Kaixiang, additional, Wang, Qixin, additional, Yin, Yan, additional, Fu, Chengcheng, additional, Xue, Sheng-Li, additional, Li, Na, additional, Zhou, Feng, additional, and Yang, Dajun, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results